Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-119
Closed -$24K 491
2018
Q3
$24K Buy
+119
New +$23.3K ﹤0.01% 126
2018
Q1
Sell
-300
Closed -$54K 610
2017
Q4
$54K Hold
300
﹤0.01% 265
2017
Q3
$48K Hold
300
﹤0.01% 267
2017
Q2
$46K Hold
300
﹤0.01% 258
2017
Q1
$38K Sell
300
-70
-19% -$8.79K ﹤0.01% 266
2016
Q4
$46K Buy
370
+21
+6% +$2.51K ﹤0.01% 218
2016
Q3
$40K Hold
349
0.01% 194
2016
Q2
$43K Hold
349
0.01% 162
2016
Q1
$39K Buy
349
+59
+20% +$6.31K 0.01% 124
2015
Q4
$31K Hold
290
0.01% 200
2015
Q3
$32K Hold
290
0.01% 232
2015
Q2
$37K Sell
290
-140
-33% -$16K 0.01% 189
2015
Q1
$46K Buy
+430
New +$42.1K 0.01% 154

Other funds holding AET

Balentine LLC's AET Position: Q4 2018 in Review

Balentine LLC sold out of Aetna Inc (AET) in Q4 2018, closing a stake of 119 shares — an estimated $24K sold.

Balentine LLC first reported a position in AET in Q1 2015 and held it in 13 quarters. The position peaked at $54K in Q4 2017. 6 funds tracked by Wall St. Rank hold AET as of Q4 2018.

  • Balentine LLC reported no remaining Aetna Inc position as of Q4 2018 after selling out during the quarter.
  • Balentine LLC sold 119 Aetna Inc shares in Q4 2018, an estimated $24K.
  • Balentine LLC first reported a position in Aetna Inc in Q1 2015 and held it in 13 quarters.
  • Balentine LLC's Aetna Inc position peaked at $54K in Q4 2017.
  • 6 funds tracked by Wall St. Rank held Aetna Inc as of Q4 2018.

Based on Balentine LLC's 13F filing for Q4 2018, filed 13 Feb 2019.